What is Ayala Pharmaceuticals Inc. ?
, a clinical-stage oncology company, primarily focuses on developing and commercializing small molecule therapeutics for patients suffering from rare and aggressive cancers in Israel and the United States.
The story behind the price, the case for and against, and what could go wrong. Open a part to read it.
, a clinical-stage oncology company, primarily focuses on developing and commercializing small molecule therapeutics for patients suffering from rare and aggressive cancers in Israel and the United States. The company is developing AL102, an oral gamma secretase inhibitor for desmoid tumors; and aspacytarabine (BST-236), a novel proprietary anti-metabolite for first line treatment in unfit acute myeloid leukemia. The company is listed on the OTCQX in USA, operating in the Healthcare sector, with a market capitalisation of 1.71M.
A short list of Biotechnology names that are close enough in size to make side-by-side comparison useful.